Jamieson Wellness Inc. (TSE:JWEL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is C$35.47.
A number of research firms recently issued reports on JWEL. CIBC lowered their target price on Jamieson Wellness from C$32.00 to C$28.00 in a report on Friday, March 15th. Royal Bank of Canada cut their target price on shares of Jamieson Wellness from C$35.00 to C$31.00 and set an “outperform” rating for the company in a research note on Thursday, March 14th. Eight Capital decreased their price target on shares of Jamieson Wellness from C$46.00 to C$38.00 in a research report on Thursday, March 14th. Scotiabank dropped their price target on Jamieson Wellness from C$32.00 to C$29.00 in a report on Thursday, March 14th. Finally, Stifel Nicolaus reduced their price objective on Jamieson Wellness from C$45.00 to C$42.00 in a research note on Thursday, March 14th.
Read Our Latest Stock Report on Jamieson Wellness
Jamieson Wellness Stock Performance
Jamieson Wellness Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 15th were issued a dividend of $0.19 per share. The ex-dividend date was Thursday, February 29th. This represents a $0.76 annualized dividend and a dividend yield of 2.91%. Jamieson Wellness’s dividend payout ratio is 70.37%.
Jamieson Wellness Company Profile
Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.
Recommended Stories
- Five stocks we like better than Jamieson Wellness
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Hilton Demonstrates Asset Light is Right for Investors
- How to Use the MarketBeat Dividend Calculator
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.